PRESS RELEASE

Introducing OFI, An AI-Powered Product That Prospectively Identifies Revenue At-Risk and High-Cost Opportunities for Improvement to Reduce MLR
SpectraMedix Introduces OFI, A Groundbreaking AI-Powered Product That Prospectively Identifies Revenue At-Risk and High-Cost Opportunities for Improvement to Reduce MLR
New AI capability flags emerging MLR risk early, traces it to specific providers and members, and routes it for in-year action.
FOR IMMEDIATE RELEASE
PRINCETON, N.J. — SpectraMedix today announced OFI, a new AI-powered product that flags prospective revenue at risk and high-cost opportunities for improvement to reduce MLR while tracing correlation to the provider and members behind it.
Health plans are under sustained margin pressure from rising medical costs, decreasing reimbursement rates, and ongoing subsidy changes. Most health plans do not see that MLR pressure until it’s already effected their bottom line — a quarter-end MLR report, a HEDIS/Stars miss, a settlement surprise.
OFI closes that gap. It runs continuously across quality, risk, utilization, attribution, and financial data, applying SpectraMedix’s proprietary SDIA framework: Signal, Driver, Impact, Action. Each finding shows what changed, why, who’s driving it, what it’s worth in dollars, and what to do next.
“OFI is built on an AI platform that runs analytics on more than a billion claims across thousands of value-based contracts. It runs on a catalogue of signals mapped through our SDIA framework,” said Kashish Goyal, Vice President of Analytics and AI at SpectraMedix. “Every signal traces back through the provider and member nodes that produced it, so the financial outcome isn’t a guess it’s a deep actuarial methodology clubbed with AI that can bend the cost curve if acted on in an appropriate manner”
The differentiator is traceability. OFI doesn’t just flag that MLR is moving it traces the finding to the specific providers and members responsible. It also routes clinical findings directly into care coordination workflows, so detection and intervention happen on the same timeline instead of separate ones.
“This gives me executive-level findings I can take straight to our leadership team and the board. It tells us exactly where to prioritize our cost reduction work, and it routes directly into our customized medical economics, provider enablement and care management strategies,” Vice President, Provider Network and Value-Based Care at Regional Health Plan. “We used to bring in consultants for months to get this kind of analysis. Now it’s available on demand.”
OFI is part of SpectraMedix's broader Connected Intelligence strategy, which helps healthcare organizations connect data, align stakeholders, and drive action across clinical, operational, and financial performance.
About SpectraMedix
SpectraMedix empowers healthcare organizations with Connected Intelligence solutions that transform complex data into actionable insights. By connecting clinical, claims, quality, risk, utilization, operational, and financial data, SpectraMedix helps healthcare organizations improve performance, accelerate value-based care success, and achieve measurable outcomes.
Learn More Here!
